Phosphagenics raising cash for R&D
Australian biotech company Phosphagenics is looking to raise A$11.25 million in a share placement to fund its core R&D programme and other expenses.
News, Analysis & Insights on Nutrition, Supplements, and Health
Australian biotech company Phosphagenics is looking to raise A$11.25 million in a share placement to fund its core R&D programme and other expenses.
The UK's poor dietary habits are costing its health service an annual £6 billion (€8.9bn) - three times as much as the financial toll from smoking - suggests a new study.
BioCell Technologies has revamped its bovine-derived CMO (cetyle myristoleate) ingredient for joint health, offering a powder at a higher concentration than previously and a new oil that extends its applications.
High fat-low carb diets, such as the once-trendy Atkins diet, appear to negatively impact the heart's energy stores, shows new research presented in the US this week.
Ocean Nutrition Canada has developed the technology to add omega-3 to chews without them tasting fishy, and is broadening out its ingredients-only business model to supply them on a bulk basis.
Mandatory serious adverse events reporting for dietary supplements is inevitable and, so long as there are protections in place, will be good for the industry, according to the three main associations.
Men who consume a lot of calcium may have a higher risk of developing prostate cancer, concludes new research.